Cover Image
市場調查報告書

冠狀動脈支架:新興市場(巴西,俄羅斯,印度,中國,南非,韓國)

Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018

出版商 Axis Research Mind 商品編碼 307375
出版日期 內容資訊 英文 540 Pages; 138 Tables/Charts
商品交期: 最快1-2個工作天內
價格
Back to Top
冠狀動脈支架:新興市場(巴西,俄羅斯,印度,中國,南非,韓國) Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018
出版日期: 2014年11月11日 內容資訊: 英文 540 Pages; 138 Tables/Charts
簡介

BRICSS各國的冠狀動脈支架市場主要受到藥物釋放型型支架,傳統金屬支架,吸收型支架等,2016年預測其規模將達到10億美元。就國別結構來看,中國約佔28%居首,其次為佔23%以上的印度。CAGR方面印度則是最急速成長的市場,中國與韓國次之。

本報告提供新興市場(巴西,俄羅斯,印度,中國,南非,韓國)的冠狀動脈支架市場相關調查分析,提供您目前市場趨勢與預測,也包含主要企業簡介(M&A,夥伴關係,產品銷售,技術開發)等系統性資訊。

第1章 觀點

  • 簡介
    • 心臟病學
    • 心臟的各種條件
      • 心臟內血流
      • 心臟功能不全
      • 心肌
      • 心膜
      • 心臟瓣膜
      • 先天性心臟缺陷
      • 血管障礙
      • 心臟麻痺(HF)
  • 心血管設備
    • 血管內動脈瘤修復·置換設備
    • 防止冠狀動脈血管症候群的方法
    • 心血管疾病的工具
    • 診斷檢驗與治療
    • 結論
  • 介入心臟病
    • 介入診斷及其技術
      • 靜脈內超音波(IVUS)
      • 光學相干斷層掃瞄(OCT)
      • 血流預備數量比(FFR)
  • 介入心臟設備
    • 冠狀動脈支架
    • 支架技術的進步:預測與新的開發
    • 冠狀動脈支架的塗料方法
      • 無機塗料
      • 聚合物塗料
      • 非聚合物塗料/表面加工
      • 其他的塗料/方法
    • 美國的心臟支架的使用
      • 藥物釋放型型支架(DES)
      • 傳統金屬支架(BMS)
      • 吸收型支架/生物分解性金屬支架
      • 血管再阻塞防止設備
      • 支架技術新的方向性
  • 冠狀動脈支架 - 類型和支架塗料 - 市場概要
    • 中國
    • 印度
    • 巴西
    • 俄羅斯
    • 韓國
    • 南非

第2章 市場分析

  • 冠狀動脈支架 - BRICSS各國 - 產業概要
    • 冠狀動脈支架 - 區分
    • 冠狀動脈支架 - 類別
    • 冠狀動脈支架 - BRICSS各國 - 類別
    • 按冠狀動脈支架 - 支架塗料
    • 按冠狀動脈支架 - BRICSS各國 - 支架塗料
  • 成長率分析
  • 投資的焦點

第3章 產業概要

  • 心臟醫療設備類型的檢驗
    • 心律管理設備
    • 心臟去顫器
    • 心臟心律調節器
    • 心臟再同步治療(CRT)
    • 心臟監測·診斷設備
    • 介入心臟設備
    • 冠狀動脈支架
    • 心導管
    • 電生理學導管(EP)
    • EP製圖
    • 心房纖維顫動(AF)
    • 靜脈內超音波(IVUS)
    • 末梢血管設備
    • 動脈切開封堵器
    • 栓塞保護裝置(EPD)
    • 下腔靜脈(IVC)過濾器
    • 末稍血管用導管導引線
    • 動靜脈通路血栓切除
    • 人工心臟瓣膜
  • 心臟設備:死亡風險 vs. 年齡
  • 心臟疾病:經濟觀點
    • 心血管疾病的經濟成本
    • 2030年心血管疾病的費用將增至3倍
    • 心血管疾病大部分皆能預防
  • 非洲等地的感染性·心血管疾病
  • 心血管設備方面FDA的最近趨勢與核准
  • 市場趨勢
  • 主要企業簡介
    • 北美
    • 歐洲
    • 亞太地區
    • 其他
  • 其他主要企業的產業活動/產品銷售
  • 心臟設備(上市·正在開發)
  • 心臟醫療設備 - 專利
  • 主要企業的財務概要

第4章 產業企業的資料庫

第5章 附錄

  • 調查的焦點
  • AXIS RESEARCH 關於MIND
  • 免責聲明
  • 回饋

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: ARMMR142N.1

SEGMENTATION - By TYPE & STENT COATING

BY TYPE

  • a. DRUG-ELUTING STENTS (DES)
  • b. BARE METAL STENTS (BMS)
  • c. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT
  • d. ANTI-RESTENOSIS DEVICES
    • I. BIOACTIVE STENT
    • II. RADIOACTIVE STENT
    • III. DRUG-ELUTING BALLOON

BY STENT COATING

  • a. INORGANIC (PERSE, GOLD, SILICON CARBIDE, IRIDIUM OXIDE, CARBON, TITANIUM-NITRIDE-OXIDE)
  • b. POLYMER (BIODEGRADABLE & NON-BIODEGRADABLE)
  • c. NON-POLYMER (MICROPOROUS, MICROSTRUCTURED, SLOTTED TUBULAR, NANOPOROUS, NANOPATTERNED)
  • d. OTHER COATINGS (HEPARIN, HYALURONIC ACID, FIBRIN), TECHNOLOGIES & R&D

CORONARY STENTS - BRICSS MARKET WATCH, 2012-2018

BRICSS Coronary Stents market value is expected to reach US$1 billion by 2016, primarily supported by the product types - Drug Eluting Stents, Bare Metal Stents, Absorbable Stents and ...etc. China accounts for nearly 28% of the market share and India claims more than 23%. In terms of CAGR, India is the fastest growing region while China and South Korea are just behind. Among the product types, Drug Eluting Stents account more nearly half of the market value while Absorbable Stents segments indicate a close 14%. In case of Stent Coating, Polymer depicts the largest CAGR while Non-Polymer and Inorganic in second and third place respectively.

“Getting the Most from Our Research Analysis”

Healthcare Industry division has been witnessing a drastic change regarding the new innovation and technology which in terms are applied in improving from sector to sector since the past 3-5 years. Cardiovascular industry growth continues to increase with the presence of multiple technologies such as advanced material and software which is featured in most of the devices. International companies tends to innovate, develop new products and to enhance the existing features in cardiovascular devices.

BRICSS CORONARY STENTS - MARKET SHARE BY STENTS COATING - 2015%

REPORT FOCUS

The report ‘Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2012-2018' reviews the latest trends in cardiovascular devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for market start-ups, pharmaceutical/biotechnology companies, laboratories, Contract/Clinical/Commercial Research Organizations (CROs), government/academic organizations, consulting firms, database buyers and many more in preferred locations.

“Learn High Potential Market Dynamics for Strategic Business Planning”

The report focuses on the current market trends, estimates and forecasts for the period 2012-2018. More than 727 market players are identified in cardiovascular devices industry out of which 122 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

KEY COMPANIES PROFILED

ABBOTT VASCULAR DEVICES, ACCELLENT, INC., AEROTEL MEDICAL SYSTEMS, LTD., ANGIODYNAMICS, INC., ASAHI INTECC CO., LTD., ASAHI KASEI CORPORATION, BERLIN HEART GMBH, BIOHEART, INC., BIOSENSORS INTERNATIONAL GROUP, LTD., BIOTRONIK GMBH & CO. KG., BOSTON SCIENTIFIC CORPORATION, C. R. BARD, INC., CAMBRIDGE HEART, INC., CARDIOCOMM SOLUTIONS, INC., CARDIOROBOTICS, INC., COOK GROUP INCORPORATED, DRÄGER MEDICAL AG & CO. KG, ESAOTE S.P.A, FUDAN UNIVERSITY ZHONGSHAN HOSPITAL, GE HEALTHCARE, HEARTWARE LTD., INDRAPRASTHA APOLLO HOSPITAL, ITGI MEDICAL LTD., MEDTRONIC, INC., MERIT MEDICAL SYSTEMS, INC., MOLECULAR DEVICES, LLC, NIHON KOHDEN CORPORATION, SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD., SORIN GROUP USA, INC., SPECTRANETICS INTERNATIONAL B.V, ST. JUDE MEDICAL, USCOME LIMITED and many more...

GEOGRAPHIC COVERAGE

The region-wise distribution consists of Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea) analyzed individually.

Table of Contents

I. REPORT FOCUS

  • A. INTRODUCTION

CARDIOLOGY

KINDS OF CARDIAC CONDITIONS

A. BLOOD FLOW IN THE HEART

B. HEART MALFUNCTION

  • TYPES OF CARDIAC ARREST

C. MYOCARDIUM

  • DISORDERS OF MYOCARDIUM

D. PERICARDIUM

E. HEART VALVES

  • DISORDERS OF HEART VALVES

F. CONGENITAL HEART DEFECT

  • TYPES OF CONGENITAL HEART DEFECT

G. AILMENTS OF BLOOD VESSELS (VASCULAR DISEASES)

H. HEART FAILURE

B. CARDIOVASCULAR DEVICES

  • DEVICES FOR ENDOVASCULAR ANEURYSM REPAIR AND REPLACEMENT
  • TECHNIQUES TO PREVENT CORONARY BLOOD VESSEL SYNDROME
  • TOOLS DEPLOYED IN CARDIOLOGY
  • DIAGNOSTIC TESTS AND PROCEDURES
  • CONCLUSION

C. INTERVENTIONAL CARDIOLOGY

A. INTERVENTIONAL DIAGNOSTICS AND ITS TECHNOLOGIES

I. INTRAVENOUS ULTRASOUND (IVUS)

II. OPTICAL COHERENCE TOMOGRAPHY (OCT)

III. FRACTIONAL FLOW RESERVE (FFR) - A BIG TECHNOLOGICAL BREAKTHROUGH

  • IMPLICATIONS OF FFR GROWTH - FALL IN USE OF GUIDEWIRES AND DES IN PATIENTS WITH MULTIVESSEL STENOSES
  • FFR HAS GREATER IMPACT ON THE GLOBAL MARKET IN THE LONG TERM
  • EMERGING RIVAL TECHNOLOGIES: CT-FFR AND IFR
  • THE RESULTS OF A CLINICAL TRIAL COMPARING IFR TO FFR
  • PERCUTANEOUS CORONARY INTERVENTION (PCI)

B. INTERVENTIONAL CARDIAC DEVICES

CORONARY STENTS

ADVANCES IN STENT TECHNOLOGY: EXPECTATIONS AND NEW DEVELOPMENTS

  • STENT SCAFFOLD STRUCTURE

CORONARY STENT COATING TYPES - IN BRIEF

  • TYPES OF STENT COATINGS, IN BRIEF:-

A. INORGANIC COATINGS

  • GOLD
  • SILICON CARBIDE
  • IRIDIUM OXIDE
  • CARBON
  • TITANIUM-NITRIDE-OXIDE

B. POLYMER COATINGS

  • NON-BIODEGRADABLE POLYMERS
  • BIODEGRADABLE POLYMERS

C. NON-POLYMER COATINGS/SURFACES:

  • MICROPOROUS SURFACES
  • MICROSTRUCTURED SURFACES
  • SLOTTED TUBULAR SURFACES
  • NANOPOROUS SURFACES
  • NPS
  • NANO-PATTERNED SURFACES

D. OTHER COATINGS/STRATEGIES

  • HEPARIN
  • HYALURONIC ACID (HA)
  • FIBRIN
  • ENDOTHELIAL CELLS (EC)
  • CONCLUSION

CARDIAC STENT USAGE IN THE US

  • PROCEDURES PERFORMED
  • PREFERRED STENT TYPE
  • STENT FACTORS AND THE IMPORTANCE OF VENDOR RELATIONSHIPS

A. DRUG-ELUTING STENTS (DES)

  • DIAGNOSTICS LIKELY TO CHANGE DES USAGE
  • INTRAVENOUS DIAGNOSTICS: THE FUTURE GATEKEEPER FOR STENT USAGE
  • DES: THE NEXT TARGET FOR MEDICAL SPENDING CUTS
  • DES AT THE FOREFRONT OF PRICE CUTS AND USAGE LIMITATION
  • ASIAN-BORN INNOVATION TO TARGET A DECLINING DES MARKET IN FUTURE
  • THE BEST STENTS AVAILABLE IN MARKET AND INNOVATIONS ARE ON THE WAY
  • GROWTH TREND OF ASIAN COMPANIES COMPARABLE TO US COMPANIES' IN THE LATE 90'S
  • US AND JAPAN BREAKDOWN OF PCI CASES
  • GLOBAL DRUG-ELUTING STENT MARKET LIKELY TO DECLINE
  • NEXT GENERATION STENTS - BVS, SYNERGY, TCD-10023 AND BIOFREEDOM
  • FIRST-GENERATION STENTS
  • SECOND-GENERATION STENTS
  • THIRD-GENERATION STENTS

B. BARE METAL STENTS (BMS)

  • BARE-METAL AND DRUG-ELUTING STENTS MARKET

C. ABSORBABLE STENTS/BIODEGRADABLE METALLIC STENT

  • BIOABSORBABLE STENT SCAFFOLDS
  • SELF-EXPANDING STENT SCAFFOLDS
  • MICROMESH COVERED STENT
  • DEDICATED BIFURCATION STENTS
  • SPECULATION ON BIO-ABSORBABLE STENTS

D. ANTI-RESTENOSIS DEVICES

  • VASCULAST™ - DRUG ELUTING COATING
  • COVIDIEN COMMENCES PATIENT ENROLMENT IN ANTI-RESTENOSIS STUDY
  • DRUG ELUTING BALLOONS
  • CONCLUSION

NEW DIRECTIONS FOR STENT TECHNOLOGY

  • STRONG GROWTH EXPECTED FOR BIOABSORABLE STENTS IN EUROPE, UNITED STATES
  • BIOSENSORS, ABBOTT, ART EMERGE AS BIOABSORABLE STENT COMPETITORS
  • BIFURCATED STENTS TO ENTER THE U.S. MARKET, EUROPEAN MARKET SEES DOUBLE DIGIT GROWTH

D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING

  • CHINA
  • INDIA
  • BRAZIL
  • RUSSIA
  • SOUTH KOREA
  • SOUTH AFRICA

II. MARKET ANALYSIS

  • CORONARY STENTS - BRICSS - INDUSTRY SNAPSHOT

A. CORONARY STENTS - SEGMENTATION

  • CORONARY STENTS - GLOBAL
  • CORONARY STENTS - BRICSS

CORONARY STENTS - BY TYPE

CORONARY STENTS - BRICSS - BY TYPE

  • DRUG-ELUTING STENTS (DES)
  • BARE METAL STENTS (BMS)
  • ABSORBABLE STENTS
  • ANTI-RESTENOSIS DEVICES

CORONARY STENTS - BY STENT COATING

CORONARY STENTS - BRICSS - BY STENT COATING

  • INORGANIC COATING
  • POLYMER COATING
  • NON-POLYMER COATING
  • OTHER STENT COATINGS

B. GROWTH RATE ANALYSIS

  • BRICSS CORONARY STENTS - MARKET GROWTH RATES
  • BRICSS CORONARY STENTS - TYPE - GROWTH RATES
  • BRICSS CORONARY STENTS - STENT COATING - GROWTH RATES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

  • FREQUENT OCCURRENCES OF CARDIOVASCULAR DISEASES WITNESS IMPROVEMENTS IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
  • AN ENCOURAGING JAB FOR TORPID PERIODS

A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES

CARDIAC RHYTHM MANAGEMENT DEVICES

  • CRM IN EUROPE

CARDIAC DEFIBRILLATORS

  • RAPID GROWTH IN DEFIBRILLATOR SALES

CARDIAC PACEMAKER DEVICES

  • THE DATA COLLECTION WORK

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

CARDIAC MONITORING AND DIAGNOSTIC DEVICES

  • THE PROGRESSIVE AND FREQUENT OCCURRENCES OF HEART DISEASES TO ENCOURAGE HUGE DEMAND OF DIAGNOSTIC CARDIAC MONITORING SYSTEMS
  • INCORPORATION OF SYSTEMS WITH EMR TO BOOST EXTENDED GROWTH OF MARKET
  • THE NORTH AMERICAN CARDIAC MONITORING DEVICES MARKET OVERVIEW

INTERVENTIONAL CARDIAC DEVICES

CORONARY STENTS

  • EVOLUTION OF STENT TECHNOLOGY ATTRACTS HUGE ATTENTION

FFR IMPACT ON DES MARKET

  • MARKET FORECASTS AN IMPACT OF FFR AND OCT ON THE DES MARKET

CARDIAC CATHETERS

  • COMPETITIVE ANALYSIS

ELECTROPHYSIOLOGY CATHETERS (EP)

  • GROWTH IN ELECTROPHYSIOLOGISTS IN EUROPE
  • DIAGNOSTIC EP CATHETERS, ABLATION DEVICES SEE STRONG INDUSTRY GROWTH

EP MAPPING

  • NEW AF ABLATION DEVICES SEEK APPROVAL

ATRIAL FIBRILLATION (AF)

INTRAVASCULAR ULTRASOUND (IVUS)

  • GO WITH THE FLOW: FRACTIONAL FLOW RESERVE, THAT IS

PERIPHERAL VASCULAR DEVICES

ARTERIOTOMY CLOSURE DEVICES

EMBOLIC PROTECTION DEVICES (EPD)

INFERIOR VENA CAVA (IVC) FILTERS

  • CONCLUSION

PERIPHERAL GUIDEWIRES

AV ACCESS THROMBECTOMY DEVICES

PROSTHETIC HEART VALVES

SWISS CARDIOVASCULAR DEVICES: A MARKET REVIEW

  • MARKET CHALLENGES

B. CARDIAC DEVICES: MORTALITY RISKS V/S AGE

  • DRIVERS IN THE MEDICAL IMPLANT INDUSTRY
  • SIZE AND WEIGHT
  • POWER EFFICIENCY
  • PERFORMANCE SPECIFICATIONS
  • RISK MITIGATION AND RELIABILITY
  • EXCITING FUTURE PREDICTED FOR ADVANCED CARDIOVASCULAR DEVICES

C. CARDIAC DISEASE: AN ECONOMIC PERSPECTIVE

  • CARDIOVASCULAR DISEASE (CVD) AND ITS EFFECTS ON HEALTH AND ECONOMY
  • IMPACT OF CVD IN EUROPE
  • IMPACT ON NEW YORK STATE
  • ECONOMIC IMPACT OF CVD IN NYS
  • HEALTH AND ECONOMIC IMPACT OF HEART DISEASE PREVENTION
  • IMPACT OF CVD ON ECONOMIC STABILITY

ECONOMIC COST OF CARDIOVASCULAR DISEASES

COST OF CARDIOVASCULAR DISEASE TO TRIPLE BY 2030

CARDIOVASCULAR DISEASE IS LARGELY PREVENTABLE

D. INFECTIOUS AND CARDIOVASCULAR DISEASES IN AFRICA AND BEYOND

E. RECENT FDA ACTIONS AND APPROVALS IN CARDIOVASCULAR DEVICES

F. MARKET TRENDS

  • PATIENT ENROLLMENT BY CARDIAC DIMENSIONS IN TITAN II CLINICAL TRIAL
  • CEDARS-SINAI HEART INSTITUTE STUDY: STEM CELLS AUGMENTS HEART'S NATURAL REPAIR SYSTEMS
  • GE HEALTHCARE'S DISCOVERY IGS 730 SYSTEM, AN INNOVATION FOR HYBRID OPERATING ROOMS
  • GE'S AUTOMATED FUNCTION IMAGING FOR DAILY CLINICAL USE.
  • CRYOLIFE RECEIVES EXPANDED INDICATION FOR BIOFOAM IN CARDIOVASCULAR SURGERIES IN EUROPE
  • INNOVATIVE PROCEDURES TO TREAT PERIPHERAL ARTERY DISEASE (PAD)
  • TASK FORCE® MONITOR DEMONSTRATED AS EFFECTIVE AUTONOMIC BIOMARKER IN CFS PATIENTS
  • INNOVATION IN INTERVENTIONAL CARDIOLOGY: CATHETER RETRIEVAL OF INFECTIVE FLORA AND MOVABLE CLOTS FROM CARDIAC VALVES AND COMPARTMENTS
  • STEREO-TAXIS UNVEILS LATEST ELECTROPHYSIOLOGY PLATFORM: EPOCH (TM)
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • VICOR TECHNOLOGIES ACQUIRES FDA CLEARANCE OF 510(K) FOR ITS PD2I® NONLINEAR ALGORITHM AND SOFTWARE TO BE EMPLOYED IN CARDIOVASCULAR DISEASE TESTING
  • STEREO TAXIS REPORTS DEVELOPMENT OF CATHETER STRATEGIC AFFILIATION
  • GLP PRE-MEDICAL STUDIES EXHIBIT NCONTACT ABLATION LESIONS ARE COMPREHENSIVE AND TRANSMURAL
  • MODERNIZATIONS IN INTERVENTIONAL CARDIOLOGY: TECHNOLOGY, FINANCES AND POLITICAL POLICIES
  • B. BRAUN'S INTROCAN SAFETY® 3 CLOSED IV CATHETER IS PRESENTED WITH TOP INNOVATION AWARD
  • MID SECURES FIRST TRANCHE OF $5 MILLION SERIES B FINANCING
  • RESEARCH REVEALS THAT HUMAN HEARTS PRODUCES NEW CELLS AFTER BIRTH
  • A NEW TYPE OF NERVE CELL IDENTIFIED IN THE BRAIN
  • ROCHE TO ADVANCE 240 MILLION SWISS FRANCS IN DIAGNOSTICS PRODUCTION IN GERMANY
  • SORIN GROUP ANNOUNCES INVESTMENT IN HIGHLIFE.
  • FIRST 34 U.S. PATIENTS IMPLANTED WITH BIOTRONIK'S NEW EVIA HF-T PACEMAKER.
  • AORTECH LNTERNATIONAL PLC CLAIMS MATERIAL BREACH OF CONTRACT BY DIVISION OF ST. JUDE MEDICAL
  • SPECTRANETICS LAUNCHES U.S COMMENCEMENT OF THE TAPAS(TM) CATHETER AND PRECLINICAL ANIMAL DATA ON DRUG UPTAKE IN PERIPHERAL VESSELS
  • USCOM MAKES PRESENTATIONS AT WORLD HYPERTENSION CONGRESS
  • MORTARA INSTRUMENT, INC. LAUNCHES “BUILT WITH PRIDE IN MILWAUKEE” CAMPAIGN.
  • MALLINCKRODT JOINS PARTNERSHIP AT DRUGFREE.ORG TO INTRODUCE MEDICINE ABUSE PROJECT
  • DRUG-ELUTING STENTS ARE SECURE
  • CARDIAC SCIENCE BEGS TOP RANKING MD BUYLINE'S USER SATISFACTION SURVEY
  • ARTIFICIAL HEART SUCCESSFULLY IMPLANTED IN A BABY IN JAPAN FOR THE FIRST TIME
  • ARTERIAL REMODELING TECHNOLOGIES ANNOUNCES FIRST HUMAN USE OF ITS NEXT-GENERATION BIORESORBABLE STENT
  • ATRIUM MEDICAL CORPORATION RECEIVES PREMIER PERFORMANCE AWARD FOR OPERATIONAL EXCELLENCE.
  • BAYER HEALTHCARE DISCLOSES ADVANCES IN CT CONTRAST DOSE MANAGEMENT™ SOLUTIONS.
  • HRS: REMOTE PATIENT MONITORING TO MINIMIZE UNPLANNED ED ADMINS
  • FUTURE HOME HEALTH CARE EQUIPMENT TREND- TECHNOLOGY OUTLOOK
  • FORTUNE MAGAZINE NAMED ST. JUDE MEDICAL AS THE “MOST ADMIRED COMPANY”
  • BIOTRONIK OPENS NEW ASIA PACIFIC HEADQUARTERS IN SINGAPORE
  • COOK MEDICAL TO INVEST €16.5M IN IRISH MEDICAL TECHNOLOGY MARKET
  • MAJOR EVENTS IN CARDIOVASCULAR MEDICAL DEVICE SPACE
  • MEDICAL IMAGING EQUIPMENT OF SIEMENS HEALTHCARE WINS LARGEST ORDER IN LATIN AMERICA.
  • NEGATIVE TRENDS IN INNOVATION IN INTERVENTIONAL CARDIOLOGY DESPITE DECREASES IN CVD MORTALITY-INTERVENTIONAL CARDIOLOGISTS EXPRESS ANGUISH
  • FIRST IMPLANT OF BOSTON SCIENTIFIC'S WATCHMAN® DEVICE IN PATIENTS IN LATIN AMERICA
  • STUDY REVEALS THAT BAYER HEALTHCARE'S COTAVANCE® DRUG ELUTING BALLOONS WITH PACCOCATH® TECHNOLOGY REDUCED TARGET LESION REVASCULARIZATION (TLR) RATES BY 59% IN PAD PATIENTS COMPARED TO THOSE TREATED WITH UNCOATED BALLOONS.
  • USCOM PRESENTED NEW HYPERTENSION MANAGEMENT STUDY AT WORLD HYPERTENSION CONGRESS
  • SAHAJANAND MEDICAL TECHNOLOGIES AWARDED MEDICAL DEVICE COMPANY OF THE YEAR 2011
  • TERUMO CORPORATION, A WELL KNOWN PIONEER IN MEDICAL DEVICE TECHNOLOGY, CELEBRATES 90TH ANNIVERSARY
  • CARDICA ACHIEVES LANDMARK UNDER DISTRIBUTION AGREEMENT WITH CENTURY MEDICAL
  • SOLUTIONS FOR SUSTAINABLE CARDIOVASCULAR CARE AT THE EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
  • EXCOR® PEDIATRIC VENTRICULAR ASSIST DEVICE RECOMMENDED BY FDA ADVISORY PANEL FOR USE IN THE UNITED STATES.
  • ZOLL NOMINATED TO GLOBE 100 AGAIN
  • USCOM ENTERS EUROPEAN MARKETS
  • POSITIVE GROWTH AND OUTLOOK FOR BIOTRONIK IN USA AND OTHER MARKETS
  • USCOM SECURES STRONG PRESENCE IN US AND CANADA
  • CARDIOMEMS AMONG THE TOP 10 INNOVATIVE TECHNOLOGY COMPANIES
  • COVIDIEN INTRODUCES NEW GLOBAL PACKAGING
  • STENTYS'S DRUG-ELUTING STENT RECEIVES MORE REIMBURSEMENT IN GERMANY.
  • SORIN GROUP INTRODUCES THE ACHIEVEMENT OF A KEY MILESTONE IN AORTIC VALVE REPLACEMENT
  • CARDIOMEMS RECEIVES GEORGIA BIO (GABIO) 2011 DEAL OF THE YEAR AWARD
  • USCOM EYES EASTERN EUROPEAN MARKET
  • VCU SUCCESSFULLY TRANSPLANTED 900TH TOTAL ARTIFICIAL HEART
  • INNOVATIVE TRENDS IN RECENT MEDICAL DEVICES
  • INFECTIONS FROM IMPLANTED CARDIAC DEVICES
  • TYRX REACHES MILESTONE IN AIGISRX IMPLANTATION
  • HEART TRANSPLANTS SUBSTITUTED BY A PUMP
  • DEVICES FOR TREATMENT OF ATRIAL FIBRILLATIONS (AF)
  • REMOTE MONITORING OF HEART FAILURE PATIENTS
  • EFFECTS OF REMOTE MONITORING OF IMPLANTED DEVICES
  • OAKWOOD HOSPITAL AND WAYNE STATE UNIVERSITY WORKING ON HEART IMPLANTATION
  • IMPLANTABLE CARDIAC MONITOR WITH HELPFUL APPROACH
  • OVER-THE-COUNTER APPARATUS
  • BOSTON SCIENTIFICS' IMPLANTABLE DEFIBRILLATOR
  • CARDIAC SCIENCE'S NEW CARDIAC TREATMENT
  • THE ONLY SYNCHRONIZED SURGICAL AND CATHETER BASED ATRIAL FIBRILLATION
  • CARDIAC SCIENCE CORPORATION WITH CARDIAC DISEASES HEALING METHOD
  • LOCAL MEDICARE'S COVERAGE FOR HYPERTENSION WITH BIOZ(R) ICG TECHNOLOGY
  • A NEW STANDARD IN CARDIAC SPECT RECONSTRUCTION
  • A REVOLUTIONIZED ELECTROPHYSIOLOGY (EP) FOR CARDIAC
  • LIDCO PRODUCTS ACCEPTED IN SOUTH KOREA
  • INVENTION OF BI-DIRECTIONAL CARDIAC CATHETER FOR IRREGULAR HEART RHYTHMS
  • BEST AND LATEST SELF-TEACHING HEART SOUNDS
  • REPLACING VALVE WITHOUT CARDIAC SUPPORT
  • U.S. FDA GRANTS THE NAVISTAR® THERMOCOOL CATHETER FOR RAPID HEART BEAT
  • AN FDA US APPROVED TREATMENT FOR CLOGGED NECK ARTERIES
  • NEW-FANGLED SPECIALTY CATHETER BY ABBOTT AT THE USA
  • MEDICAL IMPLANT MARKETS UNDER THE INFLUENCE OF TECHNICAL TRENDS

G. KEY COMPANY PROFILES

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

OTHER KEY COMPANY INDUSTRY ACTIVITES / PRODUCT LAUNCHES

CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS

CARDIAC MEDICAL DEVICES - PATENTS

KEY COMPANIES FINANCIAL OVERVIEW

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

  • RESEARCH FOCUS
  • ABOUT AXIS RESEARCH MIND
  • DISCLAIMER
  • FEEDBACK

LIST OF TABLES/CHARTS

I. REPORT FOCUS

  • 1. COMPARISON PCI GUIDELINE IN US AND EU FOR IVUS/OCT/FFR
  • 2. LIST OF DEDICATED CORONARY BIFURCATION STENTS
  • 3. CURRENTLY AVAILABLE BARE-METAL CORONARY STENT SYSTEMS
  • 4. BIOABSORBABLE SCAFFOLDS (ADVANTAGES AND DISADVANTAGES)
  • 5. LIST OF BIOABSORBABLE STENTS WITH CHARACTERISTICS AND CLINICAL EVIDENCE
  • 6. CONTEMPORARY DRUG ELUTING BALLOONS

D. CORONARY STENTS - TYPES & STENT COATING - MARKET BRIEFING

CHINA

  • 7. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR CHINA - (2012-2018, IN USD$ MILLION)
  • 8. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF CHINESE MARKET VALUE - (2015 - 2018)
  • 9. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR CHINA - (2012-2018, IN USD$ MILLION)
  • 10. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF CHINESE MARKET VALUE - (2015 - 2018)

INDIA

  • 11. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR INDIA - (2012-2018, IN USD$ MILLION)
  • 12. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF INDIAN MARKET VALUE - (2015 - 2018)
  • 13. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR INDIA - (2012-2018, IN USD$ MILLION)
  • 14. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF INDIAN MARKET VALUE - (2015 - 2018)

BRAZIL

  • 15. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR BRAZIL - (2012-2018, IN USD$ MILLION)
  • 16. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF BRAZILIN MARKET VALUE - (2015 - 2018)
  • 17. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR BRAZIL - (2012-2018, IN USD$ MILLION)
  • 18. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF BRAZILIN MARKET VALUE - (2015 - 2018)

RUSSIA

  • 19. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR RUSSIA - (2012-2018, IN USD$ MILLION)
  • 20. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF RUSSIAN MARKET VALUE - (2015 - 2018)
  • 21. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR RUSSIA - (2012-2018, IN USD$ MILLION)
  • 22. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF RUSSIAN MARKET VALUE - (2015 - 2018)

SOUTH KOREA

  • 23. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
  • 24. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)
  • 25. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR SOUTH KOREA - (2012-2018, IN USD$ MILLION)
  • 26. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF SOUTH KOREAN MARKET VALUE - (2015 - 2018)

SOUTH AFRICA

  • 27. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 28. CORONARY STENTS TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF SOUTH AFRICAN MARKET VALUE - (2015 - 2018)
  • 29. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 30. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF SOUTH AFRICAN MARKET VALUE - (2015 - 2018)
  • 31. CORONARY STENTS - PRODUCT BY BRANDS

II. MARKET ANALYSIS

  • 32. BRICSS CORONARY STENTS - SEGMENTATION BY TYPES

CORONARY STENTS - GLOBAL

  • 33. CORONARY STENTS MARKET - GLOBAL CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)

CORONARY STENTS - BRICSS

  • 34. CORONARY STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 35. CORONARY STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 36. CORONARY STENTS MARKET - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

CORONARY STENTS - BY TYPE

  • 37. CORONARY STENTS MARKET - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES FOR BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 38. CORONARY STENTS - TYPES - DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - % OF BRICSS MARKET VALUE - (2015-2018)

CORONARY STENTS - BRICSS - BY TYPE

DRUG-ELUTING STENTS (DES)

  • 39. DRUG-ELUTING STENTS (DES) MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 40. DRUG-ELUTING STENTS (DES) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

BARE METAL STENTS (BMS)

  • 41. BARE METAL STENTS (BMS) MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 42. BARE METAL STENTS (BMS) - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

ABSORBABLE STENTS

  • 43. ABSORBABLE STENTS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 44. ABSORBABLE STENTS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

ANTI-RESTENOSIS DEVICES

  • 45. ANTI-RESTENOSIS DEVICES MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 46. ANTI-RESTENOSIS DEVICES - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

CORONARY STENTS - BY STENT COATING

  • 47. CORONARY STENTS MARKET - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS FOR BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS - (2012-2018, IN USD$ MILLION)
  • 48. CORONARY STENTS - STENT COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - % OF BRICSS MARKET VALUE - (2015-2018)

CORONARY STENTS - BRICSS - BY STENT COATING

INORGANIC COATING

  • 49. INORGANIC MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 50. INORGANIC - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE -
  • (2015-2018)

POLYMER COATING

  • 51. POLYMER MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 52. POLYMER - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

NON-POLYMER COATING

  • 53. NON-POLYMER MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 54. NON-POLYMER - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

OTHER STENT COATINGS

  • 55. OTHER COATINGS MARKET - BRICSS CURRENT TRENDS, ESTIMATES & FORECASTS FOR CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA - (2012-2018, IN USD$ MILLION)
  • 56. OTHER COATINGS - % OF CHINA, INDIA, BRAZIL, RUSSIA, SOUTH KOREA AND SOUTH AFRICA MARKET VALUE - (2015-2018)

B. GROWTH RATE ANALYSIS

BRICSS CORONARY STENTS - MARKET GROWTH RATES

  • 57. CORONARY STENTS MARKET - BRICSS - % GROWTH RATE FORECASTS - (2012-2018)

BRICSS CORONARY STENTS - TYPE - GROWTH RATES

  • 58. CORONARY STENTS - TYPES - % GROWTH RATE FORECASTS FOR DRUG-ELUTING STENTS (DES), BARE METAL STENTS (BMS), ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - (2012-2018)

BRICSS CORONARY STENTS - STENT COATING - GROWTH RATES

  • 59. CORONARY STENTS - STENT COATING - % GROWTH RATE FORECASTS FOR INORGANIC, POLYMER, NON-POLYMER AND OTHER COATINGS - (2012-2018)

C. INVESTMENT FOCUS

  • 61. CORONARY STENTS - FORECASTED CAGR% - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 61. CORONARY STENTS - TYPES - DRUG ELUTING STENTS, BARE METAL STENTS, ABSORBABLE STENTS AND ANTI-RESTENOSIS DEVICES - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL
  • 62. CORONARY STENTS - COATING - INORGANIC, POLYMER, NON-POLYMER AND OTHER & R&D - FORECASTED CAGR% - VALUE - 2012-2018 - TOP 8 COUNTRIES - USA, JAPAN, CHINA, FRANCE, INDIA, SOUTH KOREA, RUSSIA AND BRAZIL

III. INDUSTRY OVERVIEW

  • 63. INTRAVENOUS DIAGNOSTICS - BY TYPE - FFR - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 64. INTRAVENOUS DIAGNOSTICS - BY TYPE - OCT - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR USA, JAPAN, EUROPE AND REST OF WORLD - (2012-2018, IN USD$ MILLION)
  • 65. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2010, IN USD BILLION)
  • 66. PROJECTED TOTAL COSTS OF CARDIOVASCULAR DISEASES IN THE UNITED STATES OF AMERICA - (2015-2030, IN USD BILLION)
  • 67. ESTIMATED DIRECT AND INDIRECT COSTS OF CARDIOVASCULAR DISEASE BY AGE - (2012, IN USD BILLION)
  • 68. PROJECTIONS OF CRUDE CARDIOVASCULAR DISEASE PREVALENCE - (% - 2010-2030) IN THE UNITED STATES
  • 69. PROJECTED DIRECT MEDICAL COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 70. PROJECTED INDIRECT LOST PRODUCTIVITY COSTS OF CARDIOVASCULAR DISEASE - ($USD BILLION, 2010-2030) IN THE UNITED STATES
  • 71. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2014
  • 72. LIST OF APPROVALS FOR CARDIOVASCULAR MEDICAL DEVICES IN 2013
  • 73. WORLDWIDE KEY PLAYERS INTO CARDIOVASCULAR DEVICES INDUSTRY THAT PROJECT IMPROVED MARKET ACTIVITIES IN THE NEAR FUTURE
  • 74. COVERAGE OF CARDIAC DEVICES MARKETED AND PIPELINE PRODUCTS
  • 75. CARDIAC ARRHYTHMIAS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 76. CIRCADIAN RHYTHM SLEEP DISORDERS DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME - 2014
  • 77. PERIPHERAL VASCULAR DISEASE (PVD) DRUG TREATMENT PRODUCT LAUNCHES WITH GENERIC NAME
  • 78. ANNUAL SALES OF CARDIAC THERAPY PRODUCTS MARKETED BY THERAPY AREA - (2010-2012, IN US$ MILLION)
  • 79. ABIOMED, INC. - PRODUCT REVENUE, FOR 2011-2013 (IN US$ ‘000)
  • 80. ACCELLENT, INC. - NET REVENUE, FOR 2011 AND 2012 (IN US$ ‘000)
  • 81. ALERE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ ‘000)
  • 82. AMBU A/S, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN DKK MILLION)
  • 83. ANGIODYNAMICS, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ ‘000)
  • 84. ATRICURE, INC. - NET SALES BY PRODUCT IN DOMESTIC & INTERNATIONAL AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ ‘000)
  • 85. BAXTER INTERNATIONAL, INC. - NET SALES BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 & 2013 (IN USD$ MILLION)
  • 86. BECTON, DICKINSON & CO - NET SALES BY MARKET SEGMENT, FOR 2011-2013 (IN USD$ MILLION)
  • 87. BIOHEART, INC. - NET SALES, FOR 2011-2013 (IN US$ ‘000)
  • 88. BIOSENSORS INTERNATIONAL GROUP, LTD. - NET SALES REVENUE BY MARKET SEGMENT, LICENSING AND GEOGRAPHY, FOR 2012 & 2013 (IN US$ ‘000)
  • 89. BIOTELEMETRY, INC. - NET SALES REVENUE AND GROSS PROFIT, FOR 2011-2013 (IN US$ ‘000)
  • 90. BOSTON SCIENTIFIC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN USD$ MILLION)
  • 91. C. R. BARD, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 92. CARDICA, INC. - NET REVENUE, FOR 2011-2013 (IN US$ ‘000)
  • 93. COMPUMED. INC. - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 IN USD
  • 94. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT & GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 95. COVIDEN, INC. - NET REVENUE BY MARKET SEGMENT, FOR USA AND NON-USA FOR 2011-2013 (IN US$ MILLION)
  • 96. CONMED CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ ‘000)
  • 97. CRYOLIFE, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ ‘000)
  • 98. CRYOLIFE, INC. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ ‘000)
  • 99. DELTEX MEDICAL GROUP PLC - NET REVENUE BY MARKET SEGMENT, FOR 2012 AND 2013 (IN US$ ‘000)
  • 100. DIGIRAD CORPORATION - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ ‘000)
  • 101. DRÄGER MEDICAL AG & CO. KG - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 (IN US$ 'MILLION)
  • 102. EDWARDS LIFESCIENCES LLC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ 'MILLION)
  • 103. ENDOLOGIX, INC, - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 104. HEARTWARE, LTD. - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ ‘000)
  • 105. HOSPIRA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 106. INDRAPRASTHA APOLLO HOSPITAL - NET REVENUE, FOR 2012-2013 (IN INDIAN RUPEES)
  • 107. INSPIREMD, LTD. - NET REVENUE, FOR 2012-2013 (IN US$ ‘000)
  • 108. JOHNSON & JOHNSON - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 109. KONINKLIJKE DSM N.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2012 AND 2013 IN (EURO MILLION)
  • 110. LOMBARD MEDICAL TECHNOLOGIES PLC - NET REVENUE, FOR 2011-2013 (IN US$ ‘000)
  • 111. OPTO CIRCUITS (INDIA) LIMITED - NET REVENUE BY CONSOLIDATED AND STANDALONE, FOR 2011-2013 (IN INDIAN RUPEES)
  • 112. MICROPORT MEDICAL (SHANGHAI) CO. LTD - NET REVENUE, FOR 2012 AND 2013 SIX MONTHS ENDED 30TH JUNE (IN RMB‘000)
  • 113. ST. JUDE MEDICAL, INC. - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (US$ IN MILLION)
  • 114. TTK - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN INDIAN RUPEES)
  • 115. CARDIUM THERAPEUTICS, INC. - NET REVENUE, FOR 2012-2013 ENDED FOR NINE MONTHS (IN US$ MILLION)
  • 116. MERIT MEDICAL SYSTEMS, INC. - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN US$ ‘000)
  • 117. SPECTRANETICS INTERNATIONAL B.V - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ ‘000)
  • 118. VARIAN MEDICAL - NET REVENUE BY MARKET AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 119. TELEFLEX MEDICAL - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 120. ABBOTT VASCULAR DEVICES - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN US$ MILLION)
  • 121. MEDTRONIC, INC - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2012 (IN US$ MILLION)
  • 122. AORTECH INTERNATIONAL PLC - NET REVENUE BY GEOGRAPHY, FOR 2011-2013 (IN US$ ‘000)
  • 123. VOLCANO CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ ‘000)
  • 124. PHILIPS MEDICAL SYSTEMS - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ ‘000)
  • 125. ATCOR MEDICAL HOLDINGS LIMITED - NET REVENUE BY GEOAGRAPHY, FOR 2012 AND 2013 (IN US$ MILLION)
  • 126. LIDCO GROUP PLC - NET REVENUE BY PRODUCTS AND GEOGRAPHY, FOR 2011-2013 (IN GBP£ ‘000)
  • 127. SORIN GROUP USA, INC. - NET REVENUE BY MARKET SEGMENT AND GEOAGRAPHY, 2011-2013 (IN EURO MILLION)
  • 128. THORATEC CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 & 2012 (IN US$ ‘000)
  • 129. STEREOTAXIS, INC. - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2011 & 2012 (IN USD)
  • 130. F.HOFFMANN-LA ROCHE LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN CHF MILLION)
  • 131. PULSION MEDICAL SYSTEMS SE - NET REVENUE BY PRODUCT AND GEOGRAPHY, FOR 2012-2013 (IN EURO ‘000)
  • 132. NOVADAQ TECHNOLOGIES INC - NET REVENUE BY CATEGORY AND GEOGRAPHY, FOR 2011-2013 (IN USD)
  • 133. SIEMENS MEDICAL SOLUTIONS USA, INC. - NET REVENUE BY GEOGRAPHY AND MARKET SEGMENT, FOR 2012 AND 2013 (IN € MILLION)
  • 134. FUKUDA DENSHI CO. LTD - NET REVENUE BY MARKET SEGMENT, FOR 2011-2013 (IN MILLION YEN)
  • 135. NIHON KOHDEN CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN MILLION YEN)
  • 136. LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011 AND 2012 (IN YUAN)
  • 137. ASAHI KASEI CORPORATION - NET REVENUE BY MARKET SEGMENT AND GEOGRAPHY, FOR 2011-2013 (IN ‘¥' YEN)

KEY COMPANY PROFILES

NORTH AMERICA

  • ALERE, INC.
  • CARDIOROBOTICS, INC.
  • INTERFACE BIOLOGICS, INC.
  • MERIDIAN HEALTH SYSTEM, INC
  • CARDIVA MEDICAL, INC.
  • LOMBARD MEDICAL TECHNOLOGIES PLC
  • DELTEX MEDICAL GROUP PLC
  • BIOTELEMETRY, INC.
  • BIOHEART, INC.
  • ASAHI INTECC CO., LTD.
  • ANGIODYNAMICS, INC.
  • MERIT MEDICAL SYSTEMS, INC.
  • MOLECULAR DEVICES, LLC
  • ACCELLENT, INC.
  • MEDTRONIC, INC.
  • ABBOTT VASCULAR DEVICES
  • CAMBRIDGE HEART, INC.
  • GREATBATCH, INC.
  • ABIOMED, INC.
  • ADVANSOURCE BIOMATERIALS CORPORATION
  • ATRICURE, INC.
  • ATRIUM MEDICAL CORPORATION
  • BIOPHAN TECHNOLOGIES, INC.
  • BIOSENSE WEBSTER, INC.
  • BOSTON SCIENTIFIC CORPORATION
  • CARDIAC SCIENCE CORPORATION
  • CARDIACASSIST, INC.
  • CARDICA, INC.
  • COOK GROUP INCORPORATED
  • CORDIS CORPORATION
  • CRYOLIFE INC.
  • MAQUET GMBH & CO. KG
  • DIGIRAD CORPORATION
  • EDWARDS LIFESCIENCES, LLC.
  • ENDOLOGIX INCORPORATED
  • ISSYS SENSING SYSTEMS, INC
  • APTUS ENDOSYSTEMS, INC.
  • FLUXION
  • JOHNSON & JOHNSON
  • KONINKLIJKEDSM N.V.
  • MEDRAD, INC.
  • BIOCLINICA
  • MILLAR INSTRUMENTS, INC
  • MONEBO TECHNOLOGIES, INC.
  • MORTARA INSTRUMENT, INC.
  • SIEMENS MEDICAL SOLUTIONS USA, INC.
  • SONOSITE, INC.
  • SORIN GROUP USA, INC.
  • ST. JUDE MEDICAL
  • STEREOTAXIS, INC.
  • TELEFLEX, INC.
  • CARDIOVASCULARSYSTEMS, INC.
  • TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
  • TERUMO HEART, INC.
  • THORATEC CORPORATION
  • VICOR TECHNOLOGIES, INC.
  • VOLCANO CORPORATION
  • COMPUMED, INC.
  • PULSION MEDICAL SYSTEMS SE
  • 3M HEALTHCARE
  • BAXTER INTERNATIONAL INC.
  • BECTON, DICKINSON & CO.
  • NOVADAQ TECHNOLOGIES INC.
  • SCOTTCARE CARDIOVASCULAR SOLUTIONS
  • VARIAN MEDICAL SYSTEMS, INC.
  • THERMEDICS, INC.
  • LEVITRONIX, LLC
  • SUNSHINE HEART, INC.
  • ACCUTECH, LLC
  • ASH ACCESS TECHNOLOGY, INC.
  • C. R. BARD, INC.
  • CONMED CORPORATION
  • HOSPIRA, INC.
  • SURGICAL SPECIALISTIES CORPORATION
  • CARDIUM THERAPEUTICS, INC.
  • CIRCULITE, INC.
  • CARDIOCOMM SOLUTIONS, INC.

EUROPE

  • BERLIN HEART GMBH
  • ESAOTE S.P.A
  • SOPHION BIOSCIENCE A/S
  • BIOTRONIK GMBH & CO. KG.
  • DRÄGER MEDICAL AG & CO. KG
  • BIOTEQUE CORPORATION
  • SPECTRANETICS INTERNATIONAL B.V
  • AORTECH INTERNATIONAL, PLC.
  • APC CARDIOVASCULAR, LTD.
  • ARTERIAL REMODELING TECHNOLOGIES
  • GE HEALTHCARE
  • LIDCO GROUP PLC
  • PHILIPS MEDICAL SYSTEMS
  • SMITH & NEPHEW PLC
  • VASCULAR CONCEPTS
  • AMBU A/S
  • FLEMING MEDICAL LIMITED
  • COVIDIEN PLC

ASIA-PACIFIC

  • NIHON KOHDEN CORPORATION
  • ALL PRO CORPORATION
  • FUKUDA DENSHI CO., LTD.
  • SICHUAN JINJIANG ELECTRONIC SCIENCE AND TECHNOLOGY CO., LTD
  • SYNCARDIA SYSTEMS, INC.
  • MICROPORTS MEDICAL
  • LEPU MEDICAL
  • BEIJING ANZHEN HOSPITAL
  • FUDAN UNIVERSITY ZHONGSHAN HOSPITAL
  • INDRAPRASTHA APOLLO HOSPITAL
  • SAHAJANAND MEDICAL TECHNOLOGIES PVT.,LTD.
  • OPTO CIRCUITS INDIA LIMITED
  • ASAHI KASEI CORPORATION
  • ASIAN HEART INSTITUTE
  • NARAYANA HRUDAYALAYA
  • USCOME LIMITED
  • HEARTWARE LTD.
  • BIOSENSORS INTERNATIONAL GROUP, LTD.
  • ATCOR MEDICAL HOLDINGS LIMITED
  • CATHRX LTD
  • TTK HEALTHCARE
  • GOODMAN CO., LTD.

REST OF WORLD

  • INSPIREMD LTD.
  • ITGI MEDICAL LTD.
  • MEDINOL, LTD.
  • GAMIDA CELL LTD.
  • AEROTEL MEDICAL SYSTEMS, LTD.
Back to Top